Maternal receipt of magnesium sulfate does not seem to reduce the risk of neonatal white matter damage.

Leviton, A

Maternal receipt of magnesium sulfate does not seem to reduce the risk of neonatal white matter damage. [electronic resource] - Pediatrics Apr 1997 - E2 p. digital

Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.

1098-4275

10.1542/peds.99.4.e2 doi


Adrenal Cortex Hormones--therapeutic use
Brain--drug effects
Cerebral Hemorrhage--diagnostic imaging
Cerebral Palsy--diagnostic imaging
Confounding Factors, Epidemiologic
Echoencephalography
Female
Humans
Hypertension--drug therapy
Infant, Newborn
Infant, Premature
Infant, Very Low Birth Weight
Leukomalacia, Periventricular--diagnostic imaging
Logistic Models
Magnesium Sulfate--pharmacology
Odds Ratio
Pre-Eclampsia--drug therapy
Pregnancy
Pregnancy Complications, Cardiovascular--drug therapy
Prospective Studies